These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 27392184)
1. Systems biology and the quest for correlates of protection to guide the development of an HIV vaccine. Kuri-Cervantes L; Fourati S; Canderan G; Sekaly RP Curr Opin Immunol; 2016 Aug; 41():91-97. PubMed ID: 27392184 [TBL] [Abstract][Full Text] [Related]
3. Complex immune correlates of protection in HIV-1 vaccine efficacy trials. Tomaras GD; Plotkin SA Immunol Rev; 2017 Jan; 275(1):245-261. PubMed ID: 28133811 [TBL] [Abstract][Full Text] [Related]
4. Challenges in the development of an HIV-1 vaccine. Barouch DH Nature; 2008 Oct; 455(7213):613-9. PubMed ID: 18833271 [TBL] [Abstract][Full Text] [Related]
5. New approaches to design HIV-1 T-cell vaccines. Perrin H; Canderan G; Sékaly RP; Trautmann L Curr Opin HIV AIDS; 2010 Sep; 5(5):368-76. PubMed ID: 20978376 [TBL] [Abstract][Full Text] [Related]
6. Sieve analysis in HIV-1 vaccine efficacy trials. Edlefsen PT; Gilbert PB; Rolland M Curr Opin HIV AIDS; 2013 Sep; 8(5):432-6. PubMed ID: 23719202 [TBL] [Abstract][Full Text] [Related]
7. Prospects for a globally effective HIV-1 vaccine. Excler JL; Robb ML; Kim JH Vaccine; 2015 Nov; 33 Suppl 4():D4-12. PubMed ID: 26100921 [TBL] [Abstract][Full Text] [Related]
8. Vaccine nanoparticles for protection against HIV infection. Aikins ME; Bazzill J; Moon JJ Nanomedicine (Lond); 2017 Mar; 12(6):673-682. PubMed ID: 28244816 [TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review. Girard MP; Osmanov S; Assossou OM; Kieny MP Vaccine; 2011 Aug; 29(37):6191-218. PubMed ID: 21718747 [TBL] [Abstract][Full Text] [Related]
10. Aiming for successful vaccine-induced HIV-1-specific cytotoxic T lymphocytes. Yang OO AIDS; 2008 Jan; 22(3):325-31. PubMed ID: 18195558 [No Abstract] [Full Text] [Related]
11. HIV vaccine: hopes and hurdles. Chhatbar C; Mishra R; Kumar A; Singh SK Drug Discov Today; 2011 Nov; 16(21-22):948-56. PubMed ID: 21889604 [TBL] [Abstract][Full Text] [Related]
12. The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors. Koup RA; Graham BS; Douek DC Nat Rev Immunol; 2011 Jan; 11(1):65-70. PubMed ID: 21164527 [TBL] [Abstract][Full Text] [Related]
13. Genetic and immune correlates of the HIV infection and vaccine-induced immunity. Foreword. Füst G Vaccine; 2008 Jun; 26(24):2949-50. PubMed ID: 18321613 [No Abstract] [Full Text] [Related]
15. Immune correlates of HIV control. Prado JG; Carrillo J; Blanco-Heredia J; Brander C Curr Med Chem; 2011; 18(26):3963-70. PubMed ID: 21824095 [TBL] [Abstract][Full Text] [Related]
16. HIV Vaccines: One Step Closer. Low MSY; Tarlinton D Trends Mol Med; 2017 Jan; 23(1):1-3. PubMed ID: 27889424 [TBL] [Abstract][Full Text] [Related]
17. Mucosal immunity and HIV-1 infection: applications for mucosal AIDS vaccine development. Belyakov IM; Ahlers JD Curr Top Microbiol Immunol; 2012; 354():157-79. PubMed ID: 21203884 [TBL] [Abstract][Full Text] [Related]
18. Progress and obstacles in the development of an AIDS vaccine. Letvin NL Nat Rev Immunol; 2006 Dec; 6(12):930-9. PubMed ID: 17124514 [TBL] [Abstract][Full Text] [Related]
20. Challenges in the development of an effective HIV vaccine: current approaches and future directions. Klein E; Ho RJ Clin Ther; 2000 Mar; 22(3):295-314; discussion 265. PubMed ID: 10963285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]